Pages that link to "Q36470205"
Jump to navigation
Jump to search
The following pages link to Glucocorticoid-induced osteoporosis: an update (Q36470205):
Displaying 50 items.
- Treatment of Cushing disease: overview and recent findings (Q24626819) (← links)
- Parathyroid hormone pulsatility: physiological and clinical aspects (Q26798180) (← links)
- Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency (Q26821908) (← links)
- Pituitary disorders and osteoporosis (Q27008465) (← links)
- Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis (Q27324822) (← links)
- Lasting consequences of traumatic events on behavioral and skeletal parameters in a mouse model for post-traumatic stress disorder (PTSD). (Q28482465) (← links)
- Stress hormone masculinizes female morphology and behaviour. (Q30498037) (← links)
- Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus (Q33375577) (← links)
- Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa (Q33586733) (← links)
- Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy (Q33619648) (← links)
- A normal reference of bone mineral density (BMD) measured by dual energy X-ray absorptiometry in healthy thai children and adolescents aged 5-18 years: a new reference for Southeast Asian Populations (Q33644384) (← links)
- The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K/AKT pathways (Q33794181) (← links)
- A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. (Q33923332) (← links)
- Nonclassic Congenital Adrenal Hyperplasia (Q34021657) (← links)
- Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. (Q34031744) (← links)
- Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation (Q34079475) (← links)
- Teriparatide induced delayed persistent hypercalcemia (Q34118834) (← links)
- An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess (Q34316496) (← links)
- The influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus (Q34457946) (← links)
- Mutiple Spontaneous Rib Fractures in Patient with Cushing's Syndrome (Q34627986) (← links)
- The negative impact of single prolonged stress (SPS) on bone development in mice (Q34727297) (← links)
- Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? (Q34753158) (← links)
- Increased bone marrow fat in anorexia nervosa (Q34968288) (← links)
- Skeletal health of children and adolescents with inflammatory bowel disease (Q35065044) (← links)
- Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features. (Q35147216) (← links)
- Bone-immune cell crosstalk: bone diseases. (Q35592362) (← links)
- Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway (Q35725177) (← links)
- Treatment Options in Cushing's Disease (Q35740882) (← links)
- Management of severe osteoporosis (Q35852252) (← links)
- Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy (Q35858075) (← links)
- Treatment of glucocorticoid-induced osteoporsis (Q36056932) (← links)
- Glucocorticoid-induced osteoporosis: treatment update and review. (Q36059394) (← links)
- Body composition and skeletal health: too heavy? Too thin? (Q36642489) (← links)
- Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis (Q36793256) (← links)
- Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density (Q36807580) (← links)
- Glucocorticoid-induced osteoporosis: pathophysiology and therapy (Q36848804) (← links)
- Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization (Q37003240) (← links)
- Cushing's syndrome: aftermath of the cure (Q37062081) (← links)
- Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects (Q37062092) (← links)
- Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. (Q37072338) (← links)
- Body composition in multiple sclerosis (Q37082402) (← links)
- Expression of HCA2 Receptors in Femoral Epiphysis and Metaphysis of Rats with Dexamethasone-Induced Osteoporosis (Q37099608) (← links)
- Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study (Q37129537) (← links)
- BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization (Q37140444) (← links)
- Growth hormone, insulin-like growth factors, and the skeleton (Q37147591) (← links)
- A case of cushing syndrome diagnosed by recurrent pathologic fractures in a young woman (Q37192077) (← links)
- Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(-/-) mice (Q37198638) (← links)
- Glucocorticoids and osteocyte autophagy (Q37200430) (← links)
- Management of glucocorticoids-induced osteoporosis: role of teriparatide (Q37230323) (← links)
- Tissue-specific glucocorticoid action: a family affair (Q37274908) (← links)